Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin-Reference-Cited by-同舟云学术

Measurement of urinary 6-?-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin

Published:1979 Issue:2 Volume:15 Page:139-145
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Ohnhaus E. E.,Park B. K.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00609878.pdf

Reference28 articles.

1. Huffman, D.H., Shoeman, D.W., Azarnoff, D.L.: Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy-antipyrine in the urine of man. Biochem. Pharmacol.23, 197?201 (1974)

2. Huffman, D.H., Shoeman, D.W., Pentikainen, P.: The effect of spironolactone on antipyrine metabolism in man. Pharmacology10, 338?344 (1973)

3. Vesell, E.S., Page, J.G.: Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. J. Clin. Invest.28, 2202?2209 (1969)

4. Vessell, E.S., Passananti, G.T., Glenwright, P.A.: Studies on the disposition of antipyrine, aminopyrine and phenacetin using plasma, saliva and urine. Clin. Pharmacol. Ther.18, 259?272 (1975)

5. Welch, R.M., DeAngelis, R.L., Wingfield, M.: Elimination of antipyrine from salvia as a measure of metabolism in man. Clin. Pharmacol. Ther.18, 249?258 (1975)

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Post Approval Clinical Trials for Drug;International Journal of Scientific Research in Science and Technology;2022-11-05

2. Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction;Frontiers in Toxicology;2022-06-20

3. Inhibition and induction of CYP enzymes in humans: an update;Archives of Toxicology;2020-10-27

4. Quantitative evaluation of hepatic and intestinal induction of CYP3A in clinical practice;Xenobiotica;2020-01-07

5. Validation of in vitro methods for human cytochrome P450 enzyme induction: Outcome of a multi-laboratory study;Toxicology in Vitro;2019-10